Quantification of skeletal metastases in castrate resistant prostate cancer predicts progression free and overall survival.
Authors
Tait, CMoore, D
Hodgson, C
Brown, Michael D
Morris, T
Growcott, J
Malone, M
Hughes, A
Renehan, Andrew G
Clarke, Noel W
Dive, Caroline
Affiliation
The Genito Urinary Cancer Research Group, Institute of Cancer Sciences, Paterson Building, University of Manchester, M20 4BX, UKIssue Date
2014-03-03
Metadata
Show full item recordAbstract
To report a simplified and effective method for substratification of M1 castrate resistant prostate cancer by correlating progression free and overall survival with simple numeric quantification of skeletal metastases.Citation
Quantification of skeletal metastases in castrate resistant prostate cancer predicts progression free and overall survival. 2014: BJU IntJournal
BJU InternationalDOI
10.1111/bju.12717PubMed ID
24589330Type
ArticleLanguage
enISSN
1464-410Xae974a485f413a2113503eed53cd6c53
10.1111/bju.12717
Scopus Count
Collections
Related articles
- The influence of prior abiraterone treatment on the clinical activity of docetaxel in men with metastatic castration-resistant prostate cancer.
- Authors: Schweizer MT, Zhou XC, Wang H, Bassi S, Carducci MA, Eisenberger MA, Antonarakis ES
- Issue date: 2014 Oct
- Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer.
- Authors: Metwalli AR, Rosner IL, Cullen J, Chen Y, Brand T, Brassell SA, Lesperance J, Porter C, Sterbis J, McLeod DG
- Issue date: 2014 Aug
- Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
- Authors: Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Divers CH, Valderrama A, Freedland SJ
- Issue date: 2016 Dec
- A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer.
- Authors: Heck MM, Thalgott M, Schmid SC, Oh WK, Gong Y, Wang L, Zhu J, Seitz AK, Porst D, Höppner M, Retz M, Gschwend JE, Nawroth R
- Issue date: 2016 Sep
- Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer.
- Authors: Hammerich KH, Donahue TF, Rosner IL, Cullen J, Kuo HC, Hurwitz L, Chen Y, Bernstein M, Coleman J, Danila DC, Metwalli AR
- Issue date: 2017 Jul